Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-001003

Chief Financial Officer sold 45,173 shares at $2.71 ($122,487)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adams Kendra Chief Financial Officer 2026-11-12 Sale 10b5-1 −45,173 $2.71 $122,487 337,150 D
Open-market sales · 45,173 sh · avg $2.71 · $122,487
Loading xslF345X06/wk-form4_1794604206.xml…